Professor Wang Changli is the former Vice President of Tianjin Cancer Hospital, former chairman of the Lung Cancer Professional Committee of the Chinese Anti-Cancer Association, and currently Vice Chairman of the Capacity Building and Continuing Education Tumor Special Committee of the National Health Commission, Vice Chairman of the non-small cell lung Cancer Expert Committee of the Chinese Society of Clinical Oncology (CSCO), and Chairman of the Lung Cancer Professional Committee of the Tianjin Anti-Cancer Association, Director of Tianjin Lung Cancer Diagnosis and Treatment Center, Director of the Department of Surgery of Tianjin Medical University Cancer Hospital, Director of the Academic Committee of Hainan Cancer Hospital, and Special director of the Thoracic Cancer Center.
Professor Wang Changli has been engaged in the clinical work, teaching and scientific research of thoracic cancer for 40 years. He is the leader of the national key specialty thoracic surgery discipline, focusing on the early diagnosis, surgical treatment, comprehensive treatment of lung cancer and basic and clinical research related to lung cancer. He is good at dealing with various complicated and difficult thoracic malignant tumor operations and has been carrying out continuous and systematic research on lymph node dissection in lung cancer surgery for many years, which has significantly improved the cure rate of lung cancer after surgery.
With excellent surgical skills, Professor Wang Changli took the lead in carrying out artificial intelligence assisted therapy technology (minimally invasive surgical treatment of lung cancer on Da Vinci surgical robot platform) in Tianjin, opening up a new field of surgical treatment of lung cancer. In 2020, the domestic Da Vinci Surgical Robot clinical Surgery Teaching Demonstration Center for lung cancer surgery was established, which opens to more than 30 provinces and cities in China. Online live broadcast of standard robotic minimally invasive surgery and thoracoscopic surgery demonstration for lung cancer were held several times a year, which plays an important role in promoting minimally invasive surgical treatment technology for lung cancer in our country.